{
    "Trade/Device Name(s)": [
        "BreathID\u00ae Hp System"
    ],
    "Submitter Information": "Meridian Bioscience Israel Ltd.",
    "510(k) Number": "K221896",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173772"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "MSQ",
        "JJQ"
    ],
    "Summary Letter Date": "December 19, 2022",
    "Summary Letter Received Date": "June 30, 2022",
    "Submission Date": "June 28, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter Fetus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Helicobacter pylori urease enzyme"
    ],
    "Specimen Type(s)": [
        "Exhaled breath"
    ],
    "Specimen Container(s)": [
        "IDcircuit nasal cannula"
    ],
    "Instrument(s)/Platform(s)": [
        "BreathID\u00ae Hp System"
    ],
    "Method(s)/Technology(ies)": [
        "Molecular Correlation Spectroscopy (MCS)",
        "Electro-optical measurement"
    ],
    "Methodologies": [
        "Breath test",
        "Optical absorption measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Kit",
        "Device"
    ],
    "Document Summary": "FDA 510(k) summary for BreathID\u00ae Hp System, a non-invasive breath test system for detecting Helicobacter pylori infection using Molecular Correlation Spectroscopy technology",
    "Indications for Use Summary": "Aid in the initial diagnosis and post-treatment monitoring of H. pylori infection in adults and pediatric patients ages 3-17 years, by measuring changes in exhaled breath CO\u2082 isotope ratios indicative of urease activity",
    "fda_folder": "Microbiology"
}